Strattera Liver Injury Warning
Contact us for a free legal consultation about your Strattera Lawsuit
Strattera Liver Injury Warning from Drug Maker, Eli Lilly
On December 17, 2004 Eli Lilly & Co. warned that Strattera, its new drug taken by children and adults with attention-deficit/hyperactivity disorder, causes
serious liver side effects in a small number of patients.
Eli Lilly put a bold print warning on the drug's label and will also send a letter to doctors informing them of the Strattera liver injury side effects.
Strattera was launched in January 2003 and has the potential to be an investor's dream of a blockbuster for Lilly.
Eli Lilly received reports about two patients who developed the Strattera liver injury problems. Both reports were submitted to the Food and Drug Administration as required by law. After examining the two cases, Eli Lilly and the FDA agreed to add the label warning. Do you want to tell your story to a Strattera lawyer?
Teenager develops Strattera-induced liver injury
The first case involved a 14 year-old-boy who developed persistent symptoms of the flu after being on the appropriate dose of Strattera for about four months. Blood tests done by the boy's physician showed that his liver was functioning improperly.
The boy immediately stopped taking the Strattera and recovered in several weeks
without major liver damage. But the boy went back on Strattera in April because it seemed to alleviate his ADHD better than other drugs he had tried. A month later, he had to be hospitalized for jaundice, another serious liver problem. His condition improved after he stopped taking Strattera.
When a person develops a Strattera liver side effect again after going back on the drug, this raises immediate red flags and increases the likelihood that the liver injury problem was caused by the drug.
Woman gets jaundice from Strattera
A second case involving a 31-year-old-woman surfaced in early December. She got
flu symptoms and jaundice after being on Strattera for a month but recovered after stopping the drug.